Ocl

   
Google
 
Web NewDrugInformation.com

Ocl


Drug - Ocl
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate
Multiple ingredients are in alphabetical order.

Strength - 6GM/100ML;75MG/100ML;168MG/100ML;146MG/100ML;1.29GM/100ML
The potency of the active ingredient(s), Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Ocl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019284
The FDA assigned number to Ocl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ocl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 30, 1986
The date Ocl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Ocl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ocl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Ocl.

Ocl